Vedanta Biosciences Receives $50,000,000 New Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ad28193f-0adf-4867-8525-9f939f8f4cba
Date
6/7/2016
Company Name
Vedanta Biosciences
Mailing Address
19 Blackstone Street 3rd Floor Cambridge, MA 02139 USA
Company Description
Vedanta Biosciences was founded by PureTech and a team of world renowned experts in immunology and microbiology. Vedanta Biosciences is developing a class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases.
Website
http://www.vedantabio.com
Transaction Type
Venture Equity
Transaction Amount
$50,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds from the financing will be used to advance multiple clinical studies in infectious and autoimmune diseases and to scale the company’s technology platform.
M&A Terms
Venture Investor
Rock Springs Capital
Venture Investor
INVESCO Private Capital
Venture Investor
Undisclosed